Kestra Medical Technologies, Ltd. (KMTS)

About Kestra Medical Technologies, Ltd.

Kestra Medical Technologies Ltd is a commercial-stage wearable medical device and digital healthcare company focused on connected monitoring, therapeutic intervention, and data-driven clinical insights for cardiovascular disease. It has developed and is commercializing the Cardiac Recovery System platform, an integrated cardiac recovery ecosystem designed to support patients at elevated risk of sudden cardiac arrest (SCA) during vulnerable periods of recovery. The platform is anchored by the ASSURE Wearable Cardioverter Defibrillator (WCD), which continuously monitors patient heart rhythms and automatically delivers defibrillation therapy when life-threatening ventricular arrhythmias are detected. The platform also includes digital patient engagement and clinical workflow solutions.

Institutional ownership

In 13F filings for the quarter ended June 30, 2026, 102 institutions reported holding KMTS, with 58.7 million shares worth $1.5 billion in aggregate. The largest reported holders were Bain Capital Investors, FMR and T. Rowe Price. Of the 5 largest reported holders, 1 added shares, 2 reduced their positions and 2 held their positions unchanged during the quarter.

More on KMTS

• KMTS sentiment: whether news and social coverage of Kestra Medical Technologies, Ltd. leans bullish or bearish, and the stories driving it.
• KMTS ownership: all 102 reporting institutions, plus insider and congressional trades.
• KMTS financials: revenue, net income, operating margin and free cash flow by quarter and year.

Frequently asked questions